117 related articles for article (PubMed ID: 2559710)
21. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.
Castle PE; Wacholder S; Lorincz AT; Scott DR; Sherman ME; Glass AG; Rush BB; Schussler JE; Schiffman M
J Natl Cancer Inst; 2002 Sep; 94(18):1406-14. PubMed ID: 12237286
[TBL] [Abstract][Full Text] [Related]
22. Masking effect of hormonal contraceptives on discriminating quantitative features of visually normal intermediate cells in positive and negative cervical smears.
Kwikkel HJ; Boon ME; van Rijswijk MM; Rietveld WJ; Stolk JG
Anal Quant Cytol Histol; 1986 Sep; 8(3):227-32. PubMed ID: 3778614
[TBL] [Abstract][Full Text] [Related]
23. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
[TBL] [Abstract][Full Text] [Related]
24. HPV genital infections and contraception.
Litta P; Agnello A; Azzena A
Clin Exp Obstet Gynecol; 1992; 19(2):136-8. PubMed ID: 1332833
[TBL] [Abstract][Full Text] [Related]
25. Risk of precancerous cervical lesions in women using a hormone-containing intrauterine device and other contraceptives: a register-based cohort study from Denmark.
Skorstengaard M; Lynge E; Napolitano G; Blaakær J; Bor P
Hum Reprod; 2021 Jun; 36(7):1796-1807. PubMed ID: 33974685
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus infection in sexually active adolescent females: prevalence and risk factors.
Moscicki AB; Palefsky J; Gonzales J; Schoolnik GK
Pediatr Res; 1990 Nov; 28(5):507-13. PubMed ID: 2175024
[TBL] [Abstract][Full Text] [Related]
27. Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change?
Barton SE; Maddox PH; Jenkins D; Edwards R; Cuzick J; Singer A
Lancet; 1988 Sep; 2(8612):652-4. PubMed ID: 2901519
[TBL] [Abstract][Full Text] [Related]
28. The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: A systematic review.
Anastasiou E; McCarthy KJ; Gollub EL; Ralph L; van de Wijgert JHHM; Jones HE
Contraception; 2022 Mar; 107():1-9. PubMed ID: 34752778
[TBL] [Abstract][Full Text] [Related]
29. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.
Moreno V; Bosch FX; Muñoz N; Meijer CJ; Shah KV; Walboomers JM; Herrero R; Franceschi S;
Lancet; 2002 Mar; 359(9312):1085-92. PubMed ID: 11943255
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of HPV cervical infection in a family planning clinic determined by polymerase chain reaction and dot blot hybridisation.
Hallam N; Green J; Gibson P; Powis J; Bibby J
J Med Virol; 1991 Jul; 34(3):154-8. PubMed ID: 1919537
[TBL] [Abstract][Full Text] [Related]
31. Risk factors inducing the persistence of high-risk genital papillomaviruses in the normal cervix.
Vandenvelde C; Van Beers D
J Med Virol; 1992 Nov; 38(3):226-32. PubMed ID: 1337551
[TBL] [Abstract][Full Text] [Related]
32. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus in women. A three-year experience in a county hospital colposcopy clinic.
Cartwright PS; Dao AH; Reed GW
J Reprod Med; 1992 Feb; 37(2):167-9. PubMed ID: 1311381
[TBL] [Abstract][Full Text] [Related]
34. Oral contraceptive use and human papillomavirus infection in women without abnormal cytological results.
Veress G; Csiky-Mészáros T; Czeglédy J; Gergely L
Med Microbiol Immunol; 1992; 181(4):181-9. PubMed ID: 1331728
[TBL] [Abstract][Full Text] [Related]
35. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.
Koutsky LA; Holmes KK; Critchlow CW; Stevens CE; Paavonen J; Beckmann AM; DeRouen TA; Galloway DA; Vernon D; Kiviat NB
N Engl J Med; 1992 Oct; 327(18):1272-8. PubMed ID: 1328880
[TBL] [Abstract][Full Text] [Related]
36. [Human papillomavirus infections in the lower genital tract of women].
Fallani MG; Penna C; Gordigiani R; Sonni L; Maggiorelli M; Marchionni M
Minerva Ginecol; 1993 Apr; 45(4):149-58. PubMed ID: 8389432
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus and cervical neoplasia: epidemiological considerations.
Grubb GS
Int J Epidemiol; 1986 Mar; 15(1):1-7. PubMed ID: 3007381
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of bacterial vaginosis and its association with genital infections, inflammation, and contraceptive methods in women attending sexually transmitted disease and primary health clinics.
Moi H
Int J STD AIDS; 1990 Mar; 1(2):86-94. PubMed ID: 1965491
[TBL] [Abstract][Full Text] [Related]
39. [The demonstration of human papillomavirus DNA in genital lesions with and without colposcopic atypism].
Mincheva A; Slavchev B; Karag'ozov I; Vasilev N; Makaveeva V
Akush Ginekol (Sofiia); 1990; 29(4):41-4. PubMed ID: 2176436
[TBL] [Abstract][Full Text] [Related]
40. The relationship of risk factors for cervical cancer and HPV in college women.
McQuiston CM
Nurse Pract; 1989 Apr; 14(4):18, 23, 26. PubMed ID: 2540467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
